Emotion Recognition Training in Antisocial Violent Offenders With Psychopathic Traits

December 18, 2017 updated by: University Hospital Tuebingen
Impaired recognition of affective facial expressions has been conclusively linked to antisocial and psychopathy. However, little is known about the modifiability of this deficit. This study aims to investigate whether and under which circumstances the proposed perceptual insensitivity can be addressed with a brief implicit training approach.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Martin Hautzinger, Prof.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Confirmed ASPD diagnosis
  • PCL-Score available
  • arrested for committing violent crimes

Exclusion Criteria:

  • Insufficient knowledge of the German language
  • Diagnosed with schizophrenia
  • Substance abuse
  • Neurological disease (e.g. epilepsy)
  • Mental retardation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SEE Training
The training sequence comprises four weekly sessions using a modified dote-probe paradigm (fearful vs. neutral expression).
Participants are first presented with a fixation cross which indicates the beginning of a trial and is immediately followed by a bilateral presentation of a neutral and a fearful image (face) of the same model identity. The fearful expression is always replaced by an arrow pointing to the left or the right which remaines active until the participant indicates via button-press which direction the arrow is pointing to. The model identity, the position of the fearful cue and the arrow probe direction are pseudo-randomized across trials with no more than three identical sequential occurrences on each parameter. Each session consists of 360 trials in total, with 120 distinct trial types and three repetitions. Participants are trained with neutral and 75% fearful expressions only in the first session; the intensity of the fearful cue is successively decreased by 15% at every subsequent session.
Active Comparator: GAZE Training
The GAZE training sequence comprises four weekly sessions using a modified dote-probe paradigm (averted vs. directed gaze).
Participants are first presented with a fixation cross, which indicates the beginning of a trial and is immediately followed by a bilateral presentation of a direct gaze-image (neutral face) and an image of a neutral face (same model identity) displaying deviated gaze. The averted gaze-face is always replaced by an arrow pointing to the left or the right which remaines active until the participant indicates via button-press which direction the arrow is pointing to. The model identity, the position of the fearful cue and the arrow probe direction are pseudo-randomized across trials with no more than three identical sequential occurrences on each parameter. Each session consists of 360 trials in total, with 120 distinct trial types and three repetitions. Participants are trained with direct and 100% averted gaze images only in the first session; the intensity of the deviated gaze cue is successively decreased by 20% at every subsequent session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Animated morph task
Time Frame: change from pre-treatment to post-treatment after 8 weeks
Morphed images are presented, beginning with the neutral face that progresses into one of the six affective expressions. This procedure creates the impression of an animated clip depicting the development of facial emotive expressions. Participants are instructed to press a button as soon as they are able to identify the emerging expression.
change from pre-treatment to post-treatment after 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Unconscious processing of affective facial expressions during interocular suppression in a breaking Continuous flash suppression paradigm
Time Frame: pre-treatment, after 8 weeks (post-treatment)
Change in processing of unaware/unconsciously perceived emotional stimuli as assessed by number of faces correctly identified
pre-treatment, after 8 weeks (post-treatment)
Eye-Tracking
Time Frame: pre-treatment, after 8 weeks (post-treatment)
Change in recognition and visual processing of emotional faces as indicated by raw scores and group means for dwell time, total dwell time, and time to first AOI (mouth/eye region) hit
pre-treatment, after 8 weeks (post-treatment)
Ambivalence Task
Time Frame: pre-treatment, after 8 weeks (post-treatment)
Change in interpretation of ambiguous emotional faces as indicated by number of hostile judgments
pre-treatment, after 8 weeks (post-treatment)
Emotional search paradigm
Time Frame: pre-treatment, after 8 weeks (post-treatment)
Assessment of implicit perceptual biases for and explicit categorization of facial expression in an emotional search paradigm (change pre- to post-intervention)
pre-treatment, after 8 weeks (post-treatment)
Affective prosody
Time Frame: pre-treatment, after 8 weeks (post-treatment)
Change in recognition of non-verbal emotional aspects of language as assessed by number of correct classifications
pre-treatment, after 8 weeks (post-treatment)
Multifaceted empathy test
Time Frame: pre-treatment, after 8 weeks (post-treatment)
Assessment of cognitive and emotional empathy (change pre- to post-intervention)
pre-treatment, after 8 weeks (post-treatment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Schönenberg, PhD, University Hospital Tuebingen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2017

Primary Completion (Anticipated)

March 1, 2019

Study Completion (Anticipated)

December 31, 2019

Study Registration Dates

First Submitted

December 12, 2017

First Submitted That Met QC Criteria

December 18, 2017

First Posted (Actual)

December 26, 2017

Study Record Updates

Last Update Posted (Actual)

December 26, 2017

Last Update Submitted That Met QC Criteria

December 18, 2017

Last Verified

December 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SCHO 1448/3-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Violent Aggressive Behavior

Clinical Trials on SEE Training

Subscribe